All sponsors

Beacon Therapeutics

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING0
READOUTS ≤12 MONTHS0
Open Beacon Therapeutics on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
rAAV2tYF-GRK1-RPGR
NCT06333249
P2Active, not recruitingX-Linked Retinitis Pigmentosa142023-04-11
HORIZON
NCT03316560
P1/2Active, not recruitingX-Linked Retinitis Pigmentosa292023-11-09
AGTC-501 (high dose and standard corticosteroid regimen)
NCT06275620
P2Enrolling by invitationX-Linked Retinitis Pigmentosa242025-11
rAAV2tYF-GRK1-hRPGRco
NCT04850118
P2/3Active, not recruitingX-Linked Retinitis Pigmentosa852026-06-30 (+30 mo)
Landscape
NCT07174726
P2Active, not recruitingX-Linked Retinitis Pigmentosa (XLRP)102029-12-31 (+30 mo)